BCL2 and hepatocellular carcinoma: A very recent study by Shen et al., [22] showed that Akt-mTOR inhibition by perifosine downregulated Mcl-1 (another anti-apoptosis protein [23, 24]), which then sensitized Bcl-2 antagonist ABT-737-induced HCC cytotoxicity.